Latest News

Date Title Topic
29 Sep 2014 Liquid biopsies: Tumour diagnosis and treatment monitoring in a blood test Translational research - Basic science
29 Sep 2014 ESMO 2014 Press Release: RAS Testing Only the First Step for Choosing Treatment for Metastatic Colorectal Cancer, Important New Data Show Gastrointestinal cancers
29 Sep 2014 ESMO 2014: Targeted Treatments for Subsets of NSCLC Patients With Folate-Receptor-Positive, BRAF V600E-Mutant, and With Tumours Carrying HER2 Somatic Mutations Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Sep 2014 Pathway of the Day: CDK Pathology/Molecular biology
29 Sep 2014 ESMO 2014 Press Commentary: Anti-PD-L1 Antibody Shows Promising Activity in Advanced Bladder Cancer after Decades of Silence Genitourinary cancers - Immuno-oncology
29 Sep 2014 ESMO 2014 Press Release: Promising Results Shown with Targeted Approaches in Subsets of Non-Small-Cell Lung Cancer Lung and other thoracic tumours
29 Sep 2014 ESMO 2014 Press Release: New Data on Combination Treatments for Melanoma Melanoma
29 Sep 2014 ESMO 2014 Press Release: Nivolumab Shows Signs of Superior Response Rate Compared to Standard Chemotherapy in Advanced Melanoma Melanoma - Immuno-oncology
29 Sep 2014 ESMO 2014 Press Release: Studies Report New Findings on Treatment Options for Mesothelioma Lung and other thoracic tumours - Immuno-oncology - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014: Adjuvant Treatment with MAGE-A3 Cancer Immunotherapeutic in Patients with Resected NSCLC Does Not Increase Disease-Free Survival Lung and other thoracic tumours - Immuno-oncology
28 Sep 2014 ESMO 2014: Final Overall Survival Analysis from the CLEOPATRA Study in Patients with HER2-Positive Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014: Final Overall Survival Analysis of the Phase III Randomised Trial of Chemotherapy With and Without Bevacizumab for Advanced Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014: Activity of Second-Line Dovitinib in Advanced and/or Metastatic Endometrial Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014: Continuation of Gefitinib Plus Pemetrexed/Cisplatin of No Clinical Benefit in NSCLC Patients with Acquired Resistance to Gefitinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Treatments for Advanced Cancer Less Available in Eastern Europe, Reveals ESMO Survey Bioethics, legal and economic issues